Valuation: Implantica AG

Market Cap 1.5B 1.73B 1.4B 1.28B 2.41B 165B 2.45B 16.43B 6.45B 82.64B 6.5B 6.36B 275B P/E 2026 *
-16.6x
P/E 2027 * -14.4x
Enterprise Value 1.47B 1.7B 1.38B 1.26B 2.37B 162B 2.41B 16.14B 6.33B 81.16B 6.39B 6.25B 270B EV / Sales 2026 *
413x
EV / Sales 2027 * 164x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-1.02%
1 week-4.45%
Current month-6.15%
1 month-12.12%
3 months+31.07%
6 months+26.09%
Current year+15.77%
1 week 55.5
Extreme 55.5
61.2
1 month 55.5
Extreme 55.5
66.2
Current year 38
Extreme 38
69
1 year 38
Extreme 38
82
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
136.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-4.45%-15.94%+190.58% 1.73B
+0.41%+0.92%+35.55%+31.24% 12.84B
+0.93%-0.21%+20.96%+23.39% 6.87B
+5.64%+9.50%+59.16%+38.76% 6.51B
-0.51%+2.09% - - 5.48B
+1.20%-4.46%-26.80%+39.65% 4.41B
+0.77%-2.17%-21.87%-17.42% 4.08B
+5.61%+12.99%+55.53%-43.62% 2.02B
+0.92%+6.50%+68.55%-10.15% 1.71B
+1.13%+3.03%-28.31%-43.47% 1.32B
Average +1.51%+2.06%+16.31%+23.22% 4.7B
Weighted average by Cap. +1.42%+1.76%+22.71%+26.16%

Financials

2026 *2027 *
Net sales 3.57M 4.12M 3.34M 3.05M 5.75M 393M 5.84M 39.12M 15.35M 197M 15.48M 15.14M 655M 9.14M 10.56M 8.55M 7.81M 14.72M 1.01B 14.95M 100M 39.33M 504M 39.67M 38.8M 1.68B
Net income -22.17M -25.61M -20.72M -18.94M -35.69M -2.44B -36.24M -243M -95.34M -1.22B -96.15M -94.05M -4.07B -25.65M -29.63M -23.98M -21.92M -41.3M -2.83B -41.94M -281M -110M -1.41B -111M -109M -4.71B
Net Debt -26.74M -30.89M -24.99M -22.84M -43.05M -2.95B -43.72M -293M -115M -1.47B -116M -113M -4.91B -308K -356K -288K -263K -496K -33.95M -504K -3.38M -1.33M -16.98M -1.34M -1.31M -56.57M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-10 SEK 58.00 -1.02% 48,125
26-08-07 SEK 58.60 -0.51% 16,909
26-08-06 SEK 58.90 -1.01% 27,300
26-08-05 SEK 59.50 0.00% 27,889
26-08-04 SEK 59.50 -1.98% 28,351
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.292EUR
Average target price
6.725EUR
Spread / Average Target
+27.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock